Table 1.

Outcomes following aneurysm treatment. At the time of last follow-up, among all patients there were significant reductions in headache frequency, symptoms of cutaneous allodynia (ASC-12), symptoms of depression (BDI), and state anxiety. Among patients with headaches prior to aneurysm treatment there were significant reductions in headache frequency, state anxiety and trait anxiety

	All patients (n=44)			Patients with active pretreatment headaches (n=28)
	Pretreatment	Last follow-up	p	Pretreatment	Last follow-up	p
Headache days/90 days	31 (35)	17 (29)	<0.001	49 (33)	26 (33)	0.002
Headache severity	4 (3.0)	4 (4)	0.52	5 (2)	5 (3)	0.82
ASC-12	3 (4)	1 (2)	0.04	2 (2)	2 (2)	0.21
MIDAS	23 (39)	15 (34)	0.07	37 (43)	23 (40)	0.06
BDI	9 (10)	8 (9)	0.01	12 (11)	10 (11)	0.06
State anxiety	50 (6)	48 (4)	0.04	50 (6)	47 (5)	0.03
Trait anxiety	47 (5)	46 (4)	0.13	48 (5)	46 (4)	0.04

Values are means (SD).